Canonical correlation analysis of set of nonadherence measures with set of determinants
| Determinants of increased nonadherence . | Canonical loading . |
|---|---|
| Patient-related | |
| Age | 0.649 |
| Months since diagnosis of CML | 0.272 |
| Living alone | 0.246 |
| Male sex | 0.194 |
| Months on imatinib | 0.193 |
| Imatinib dose ≥ 600 mg/daily | 0.193 |
| Quality of chronic care | 0.125 |
| Functional status / quality of life* | 0.117 |
| Physician-related | |
| Median duration of treatment follow-up visits | 0.237 |
| Years of professional experience | 0.135 |
| Determinants of decreased nonadherence | |
| Patient-related | |
| Knowledge of disease and treatment | −0.314 |
| Number of medications taken per day | −0.184 |
| Secondary school graduate | −0.140 |
| Long-term medication behavior self-efficacy | −0.062 |
| Physician-related | |
| Number of patients with CML seen in past year | −0.363 |
| Median duration of first visit with patient newly diagnosed with CML | −0.119 |
| Practicing in university or university-affiliated hospital | −0.003 |
| Hematologist | −0.002 |
| Canonical model parameters | |
| Canonical correlation Wilks test, 0.484; χ2, 74.04; P, .036 | 0.509 |
| Redundancy proportion | 0.015 |
| Determinants of increased nonadherence . | Canonical loading . |
|---|---|
| Patient-related | |
| Age | 0.649 |
| Months since diagnosis of CML | 0.272 |
| Living alone | 0.246 |
| Male sex | 0.194 |
| Months on imatinib | 0.193 |
| Imatinib dose ≥ 600 mg/daily | 0.193 |
| Quality of chronic care | 0.125 |
| Functional status / quality of life* | 0.117 |
| Physician-related | |
| Median duration of treatment follow-up visits | 0.237 |
| Years of professional experience | 0.135 |
| Determinants of decreased nonadherence | |
| Patient-related | |
| Knowledge of disease and treatment | −0.314 |
| Number of medications taken per day | −0.184 |
| Secondary school graduate | −0.140 |
| Long-term medication behavior self-efficacy | −0.062 |
| Physician-related | |
| Number of patients with CML seen in past year | −0.363 |
| Median duration of first visit with patient newly diagnosed with CML | −0.119 |
| Practicing in university or university-affiliated hospital | −0.003 |
| Hematologist | −0.002 |
| Canonical model parameters | |
| Canonical correlation Wilks test, 0.484; χ2, 74.04; P, .036 | 0.509 |
| Redundancy proportion | 0.015 |
χ2 indicates chi-square test of goodness-of-fit; and P, probability of test statistic for goodness-of-fit test.
Nonstandardized scores.